Toremifene-d6

CAT: 0804-HY-B0005AS-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-B0005AS-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Toremifene-d6 is deuterium labeled Toremifene. Toremifene (Z-Toremifene) is a second-generation selective estrogen-receptor modulator (SERM) in development for the prevention of osteoporosis. Toremifene also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.07 μM and 2.6 μM, respectively[1][2].
Product Name Alternative
Z-Toremifene-d6; NK 622-d6 (free base) ; FC-1157a-d6 (free base)
UNSPSC
12352005
Target
Estrogen Receptor/ERR; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Solubility
10 mM in DMSO
Smiles
[2H]C(N(C([2H])([2H])[2H])CCOC1=CC=C(/C(C2=CC=CC=C2)=C(C3=CC=CC=C3)/CCCl)C=C1)([2H])[2H]
Molecular Formula
C26H22D6ClNO
Molecular Weight
412.00
References & Citations
[2]Gauri J Sabnis, Luciana Macedo, Olga Goloubeva, Toremifene - Atamestane; Alone or In Combination: Predictions from the Preclinical Intratumoral Aromatase Model. J Steroid Biochem Mol Biol. 2008 January; 108 (1-2) : 1-7.|[3]Laura Cooper, et al. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. J Med Chem. 2020 Sep 4.|[4]Matthew R Smith, Selective Estrogen Receptor Modulators to Prevent Treatment-Related Osteoporosis.Rev Urol. 2005; 7 (Suppl 3) : S30-S35.|[5]Taneja SS, Morton R, Barnette G, Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene. J Clin Oncol. 2013 Feb 10;31 (5) :523-9.|[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-B0005A-01Toremifene
HY-B0005-01Toremifene (citrate)
HY-B0005R-01Toremifene (citrate) (Standard)
HY-110225-01Levetiracetam-d6 (ring-d6)
HY-W705791-01Metconazole-d6
HY-32721SNeratinib-d6
HY-123533SResorufin-d6
HY-W754220Scutellarein-d6
HY-B0437SSotalol-d6
HY-13683S2-01Mifepristone-d6

Alternative Products

CatalogName
RM-T151803-01Toremifene-D6
TRC-T547502-10MGToremifene-d6 Citrate
TRC-H954512-10MG4’-Hydroxy Toremifene-d6
sc-4765204′-Pivaloyloxy Toremifene-d6
MBS6057556-014'-Hydroxy Toremifene-d6
sc-474765Toremifene N-Oxide-d6
sc-4912344′-Hydroxy Toremifene-d6
MBS6119239-014'-Pivaloyloxy Toremifene-d6
0198344’-Pivaloyloxy Toremifene-d6
TRC-H954507-10MG(E)-4-Hydroxy Toremifene-d6 (~10% Z-isomer)

Popular Products